Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations.
CANCER RESEARCH AND TREATMENT（2024）
关键词
Pemigatinib,Cholangiocarcinoma,FGFR2 fusions,FGFR2 rearrangements,Expanded Access Program
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要